KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Long-Term Investments: 2021-2023

Historic Long-Term Investments for Ginkgo Bioworks Holdings (DNA) over the last 3 years, with Dec 2023 value amounting to $78.6 million.

  • Ginkgo Bioworks Holdings' Long-Term Investments fell 29.97% to $78.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $78.6 million, marking a year-over-year decrease of 29.97%. This contributed to the annual value of $78.6 million for FY2023, which is 29.97% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Long-Term Investments of $78.6 million as of Q4 2023, which was down 7.54% from $85.0 million recorded in Q3 2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Long-Term Investments ranged from a high of $1.7 billion in Q1 2021 and a low of $78.6 million during Q4 2023.
  • Moreover, its 3-year median value for Long-Term Investments was $103.9 million (2021), whereas its average is $371.9 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Long-Term Investments tumbled by 94.84% in 2022 and then spiked by 34.67% in 2023.
  • Ginkgo Bioworks Holdings' Long-Term Investments (Quarterly) stood at $102.0 million in 2021, then grew by 9.95% to $112.2 million in 2022, then fell by 29.97% to $78.6 million in 2023.
  • Its last three reported values are $78.6 million in Q4 2023, $85.0 million for Q3 2023, and $119.9 million during Q2 2023.